trending Market Intelligence /marketintelligence/en/news-insights/trending/1AVBR4f5RsFiOF0wr6N-Ug2 content esgSubNav
In This List

Arix Bioscience leads $30M financing for Atox Bio

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Arix Bioscience leads $30M financing for Atox Bio

Arix Bioscience plc led an oversubscribed $30 million series F financing round for Atox Bio.

Participants included new investors Adams Street Partners, Asahi Kasei Corp. and additional undisclosed investors, plus existing investors SR One, OrbiMed, Lundbeckfonden Ventures, Becker and Integra Holdings.

Arix Bioscience is investing $8 million for an equity stake in Atox Bio.

As part of the financing, Arix Bioscience's Jonathan Tobin will be appointed a director of Atox Bio.